- Home
- FCEL vs VERU Comparison
FCEL vs VERU Comparison
Compare FCEL & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- VERU
- Stock Information
- Founded
- FCEL 1969
- VERU 1971
- Country
- FCEL United States
- VERU United States
- Employees
- FCEL N/A
- VERU N/A
- Industry
- FCEL Industrial Machinery/Components
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- FCEL Energy
- VERU Health Care
- Exchange
- FCEL Nasdaq
- VERU Nasdaq
- Market Cap
- FCEL 116.0M
- VERU 94.5M
- IPO Year
- FCEL 1992
- VERU 1990
- Fundamental
- Price
- FCEL $5.96
- VERU $0.58
- Analyst Decision
- FCEL Hold
- VERU Strong Buy
- Analyst Count
- FCEL 6
- VERU 2
- Target Price
- FCEL $14.11
- VERU $4.00
- AVG Volume (30 Days)
- FCEL 2.3M
- VERU 4.3M
- Earning Date
- FCEL 06-06-2025
- VERU 08-07-2025
- Dividend Yield
- FCEL N/A
- VERU N/A
- EPS Growth
- FCEL N/A
- VERU N/A
- EPS
- FCEL N/A
- VERU N/A
- Revenue
- FCEL $129,424,000.00
- VERU $16,886,419.00
- Revenue This Year
- FCEL $40.32
- VERU N/A
- Revenue Next Year
- FCEL $36.17
- VERU N/A
- P/E Ratio
- FCEL N/A
- VERU N/A
- Revenue Growth
- FCEL 48.62
- VERU 134.43
- 52 Week Low
- FCEL $3.58
- VERU $0.45
- 52 Week High
- FCEL $23.40
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- FCEL 52.86
- VERU 52.23
- Support Level
- FCEL $6.01
- VERU $0.56
- Resistance Level
- FCEL $7.15
- VERU $0.74
- Average True Range (ATR)
- FCEL 0.79
- VERU 0.05
- MACD
- FCEL -0.05
- VERU -0.00
- Stochastic Oscillator
- FCEL 34.70
- VERU 36.26
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.